Systemic sclerosis with morphea-like plaques histopathologically mimicking cutaneous B-cell lymphoma

Systemic sclerosis with morphea-like plaques histopathologically mimicking cutaneous B-cell lymphoma

Bibliographic Details
Main Authors:	Ana M. Aragon Sierra, BS, Angelina S. Hwang, BS, Jacob Kechter, BS, Aaron R. Mangold, MD, Vivek Nagaraja, MD, David J. DiCaudo, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	JAAD Case Reports
Subjects:	autoimmune disease B-cell lymphoma morphea pseudolymphoma scleroderma systemic sclerosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624000882

Similar Items

Paraneoplastic morphea with prominent mucin deposition
by: Ahmad B. Shahin, BS, et al.
Published: (2023-11-01)

A rare presentation of cutaneous T-cell lymphoma mimicking morphea
by: Beverly Yu, BA, BS, et al.
Published: (2023-03-01)

Histopathologic spectrum of morphea: a single-center retrospective study
by: Özben Yalçın, et al.
Published: (2024-02-01)

Morphea: The 2023 update
by: Cristian Papara, et al.
Published: (2023-02-01)

Association between Localized Scleroderma Cutaneous Assessment Tool and clinicopathologic characteristics in patients with morphea
by: Yıldız Gürsel Ürün, et al.
Published: (2022-09-01)

Apremilast as a treatment for morphea: A case series
by: Merav Koschitzky, BA, et al.
Published: (2022-01-01)

Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review
by: Alexy Hernandez, et al.
Published: (2024-08-01)

Taxane-induced morphea in a patient with CREST syndrome
by: Susan Michele Bouchard, et al.
Published: (2010-07-01)

Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin
by: Noah Hewitt, MD, et al.
Published: (2025-04-01)

Fracture risk in linear morphea-affected limbs: A pilot retrospective study of adult patients
by: Maha Kazmi, BS, et al.
Published: (2025-02-01)

Clinical case of morphea associated with a malignant process with extensive skin lesions, which debuted against the background of taking anti-gouty remedy
by: P. O. Kazakova
Published: (2024-11-01)

Tocilizumab for refractory morphea in adults: A case series
by: Sarah Lonowski, MD, MBA, et al.
Published: (2022-12-01)

Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea
by: Ingrid M. Ganske, MD, MPA, et al.
Published: (2022-07-01)

Nodular (keloidal) scleroderma: A case series of 5 patients
by: Michel Ntiri, BSc, et al.
Published: (2024-07-01)

Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea
by: Hilal Ayvaz Celik, et al.
Published: (2024-10-01)

Morphea-like subcutaneous panniculitis-like T-cell lymphoma
by: Keiko Tokuchi, MD, PhD, et al.
Published: (2024-04-01)

Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea
by: Sahar Dadkhahfar, et al.
Published: (2020-05-01)

Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature
by: Soroush Kazemi, BS, et al.
Published: (2022-10-01)

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01)

A case of bullous morphea
by: Qiang HU, et al.
Published: (2023-04-01)

Rapid Progression of Localized Morphea to Disseminated Plaque-Type Morphea Following COVID-19 Infection
by: Hoda Rahimi, et al.
Published: (2023-04-01)

A recurrent, painful, and indurated plaque on a 75-year-old man's back
by: Nicole Ufkes, BS, et al.
Published: (2020-06-01)

Morphea simulating paucibacillary leprosy clinically and histopathologically
by: José Saulo Torres Delgado, et al.
Published: (2013-01-01)

Zosteriform morphea: Wolf’s isotopic response in an immunocompetent patient
by: Ricardo Ruiz-Villaverde, et al.
Published: (2011-10-01)

Diagnostic Dilemmas in Cutaneous Pseudolymphomas
by: Gourang Paliwal, et al.
Published: (2022-01-01)

Association of Black Race With Demographic, Comorbidities, and Outcome Variables in Localized Scleroderma Patients: A Retrospective Analysis of the 2017 US National Inpatient Sample
by: Keshav D. Kumar, et al.
Published: (2024-10-01)

Cutaneous pseudolymphomatous drug eruption secondary to supplemental flaxseed oil
by: Emma L. Larson, MD, et al.
Published: (2022-09-01)

Red nodule on the face with “spontaneous” regression
by: Celia Sanchis-Sánchez, et al.
Published: (2017-01-01)

Clinical and Histological Characteristics of Localized Morphea, Generalized Morphea and Systemic Sclerosis: A Comparative Study Aided by Machine Learning
by: Sooyeon Choi, et al.
Published: (2023-09-01)

Narrow-band ultraviolet B as a treatment option in linear morphea
by: Andrew Yoshihiro Wirya, et al.
Published: (2022-10-01)

The role of infection in morphea disease
by: Fatemeh Farhangdoost
Published: (2015-10-01)

Frontal bone loss following coronal brow lift: A mimicker of head variant linear morphea
by: Maha Kazmi, BS, et al.
Published: (2023-11-01)

Hyaluronic Acid Filler Injection for Localized Scleroderma – Case Report and Review of Literature on Filler Injections for Localized Scleroderma
by: Sharad J
Published: (2022-08-01)

Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry
by: Eveline Y. Wu, et al.
Published: (2019-04-01)

A case of hidradenitis suppurativa with plaque morphea: Association or chance?
by: Ayesha Sharmeen, et al.
Published: (2023-01-01)

Durvalumab-associated generalized morphea with overlapping vitiligo
by: Julianna Martel, MD, et al.
Published: (2022-12-01)

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives
by: Leigh A. Stubbs, et al.
Published: (2023-04-01)

Excimer laser treatment for morphea-lichen sclerosus et atrophicus overlap in a pediatric patient
by: Emily Hong, BS, et al.
Published: (2023-02-01)

Early morphea simulating patch-stage mycosis fungoides in two cases
by: Hamid R. Ghasemi Basir, et al.
Published: (2018-04-01)

Morphea-like localized involutional lipoatrophy treated with methotrexate and hydroxychloroquine
by: Selena Osman, MSc, et al.
Published: (2024-06-01)